LYCOSOME Trademark

Trademark Overview

On Friday, November 7, 2008, a trademark application was filed for LYCOSOME with the United States Patent and Trademark Office. The USPTO has given the LYCOSOME trademark a serial number of 79064063. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, November 8, 2018. This trademark is owned by CamMEDICA Limited. The LYCOSOME trademark is filed in the Pharmaceutical Products category with the following description:

Dietary food supplements for medical use; dietary food supplements for the treatment of metabolic disorders and diabetes; dietary and nutritional supplements for medical use; dietary and nutritional supplements for the treatment of metabolic disorders and diabetes; pharmaceuticals for the treatment of metabolic disorders and diabetes; pharmaceuticals for the treatment of hypertension, chronic inflammation, heart failure, metabolic syndromes, pre-diabetes, liver staetosis, liver damage, liver cirrhosis, dermatological disorders and diseases, skin and tissue damage, cellulite, reproductive disorders and diabetes; chewing gum for medical purposes
lycosome

General Information

Serial Number79064063
Word MarkLYCOSOME
Filing DateFriday, November 7, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, November 8, 2018
Registration Number3740186
Registration DateTuesday, January 19, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2009

Trademark Statements

Goods and ServicesDietary food supplements for medical use; dietary food supplements for the treatment of metabolic disorders and diabetes; dietary and nutritional supplements for medical use; dietary and nutritional supplements for the treatment of metabolic disorders and diabetes; pharmaceuticals for the treatment of metabolic disorders and diabetes; pharmaceuticals for the treatment of hypertension, chronic inflammation, heart failure, metabolic syndromes, pre-diabetes, liver staetosis, liver damage, liver cirrhosis, dermatological disorders and diseases, skin and tissue damage, cellulite, reproductive disorders and diabetes; chewing gum for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIP Science Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGB
Party NameCamMEDICA Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameCamMEDICA Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameCamMEDICA Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Friday, May 24, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 24, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, June 16, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, May 3, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, May 3, 2017INVALIDATION PROCESSED
Wednesday, April 26, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 26, 2016CANCELLED SECTION 71
Wednesday, February 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 21, 2012NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 29, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 4, 2011CHANGE OF OWNER RECEIVED FROM IB
Wednesday, May 19, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 19, 2010FINAL DISPOSITION PROCESSED
Monday, April 19, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 19, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, November 3, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2009PUBLISHED FOR OPPOSITION
Tuesday, September 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 29, 2009ASSIGNED TO LIE
Thursday, September 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, September 16, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 25, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 25, 2009NON-FINAL ACTION E-MAILED
Tuesday, August 25, 2009NON-FINAL ACTION WRITTEN
Wednesday, August 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 5, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 9, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 9, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 6, 2009REFUSAL PROCESSED BY IB
Thursday, February 12, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 12, 2009REFUSAL PROCESSED BY MPU
Thursday, February 12, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 11, 2009NON-FINAL ACTION WRITTEN
Tuesday, February 10, 2009APPLICATION FILING RECEIPT MAILED
Monday, February 9, 2009ASSIGNED TO EXAMINER
Friday, February 6, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 5, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lycosome disorders diabetes metabolic dietary treatment supplements medical liver damage pharmaceuticals